Annual Operating Profit
-$33.33 M
-$10.06 M-43.22%
01 July 2024
Summary:
BriaCell Therapeutics annual operaing income is currently -$33.33 million, with the most recent change of -$10.06 million (-43.22%) on 01 July 2024. During the last 3 years, it has fallen by -$26.36 million (-378.04%). BCTX annual operating profit is now -387459.30% below its all-time high of -$8600.00, reached on 31 July 2006.BCTX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$5.77 M
+$3.46 M+37.51%
01 July 2024
Summary:
BriaCell Therapeutics quarterly operating income is currently -$5.77 million, with the most recent change of +$3.46 million (+37.51%) on 01 July 2024. Over the past year, it has increased by +$2.73 million (+32.17%). BCTX quarterly operating profit is now -64708.99% below its all-time high of -$8900.00, reached on 30 April 2009.BCTX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$33.33 M
+$1.94 M+5.49%
01 July 2024
Summary:
BriaCell Therapeutics TTM operating income is currently -$33.33 million, with the most recent change of +$1.94 million (+5.49%) on 01 July 2024. Over the past year, it has dropped by -$6.96 million (-26.38%). BCTX TTM operating profit is now -116847.37% below its all-time high of -$28.50 thousand, reached on 31 October 2006.BCTX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCTX Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -43.2% | +32.2% | -26.4% |
| 3 y3 years | -378.0% | -152.4% | -275.5% |
| 5 y5 years | -558.0% | -391.3% | -522.0% |
BCTX Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -378.0% | at low | -152.4% | +41.3% | -275.5% | +5.5% |
| 5 y | 5 years | -751.1% | at low | -2934.2% | +41.3% | -1561.7% | +5.5% |
| alltime | all time | <-9999.0% | at low | <-9999.0% | +41.3% | <-9999.0% | +5.5% |
BriaCell Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| July 2024 | -$33.33 M(+43.2%) | -$5.77 M(-37.5%) | -$33.33 M(-5.5%) |
| Apr 2024 | - | -$9.23 M(-6.1%) | -$35.27 M(+11.2%) |
| Jan 2024 | - | -$9.83 M(+15.6%) | -$31.72 M(+20.3%) |
| Oct 2023 | - | -$8.50 M(+10.3%) | -$26.37 M(+13.3%) |
| July 2023 | -$23.27 M(+52.2%) | -$7.71 M(+35.7%) | -$23.27 M(+11.9%) |
| Apr 2023 | - | -$5.68 M(+26.5%) | -$20.80 M(+8.1%) |
| Jan 2023 | - | -$4.49 M(-17.0%) | -$19.25 M(+4.6%) |
| Oct 2022 | - | -$5.40 M(+3.2%) | -$18.40 M(+20.4%) |
| July 2022 | -$15.29 M(+119.2%) | -$5.23 M(+26.9%) | -$15.29 M(+31.2%) |
| Apr 2022 | - | -$4.12 M(+13.2%) | -$11.65 M(-5.5%) |
| Jan 2022 | - | -$3.64 M(+59.5%) | -$12.33 M(+38.9%) |
| Oct 2021 | - | -$2.28 M(+43.2%) | -$8.88 M(+27.3%) |
| July 2021 | -$6.97 M(+78.0%) | -$1.60 M(-66.8%) | -$6.97 M(+10.5%) |
| Apr 2021 | - | -$4.81 M(+2428.5%) | -$6.31 M(+214.6%) |
| Jan 2021 | - | -$190.10 K(-50.0%) | -$2.01 M(-38.0%) |
| Oct 2020 | - | -$380.40 K(-59.3%) | -$3.24 M(-19.7%) |
| July 2020 | -$3.92 M(-22.7%) | -$933.90 K(+86.3%) | -$4.03 M(-16.2%) |
| Apr 2020 | - | -$501.40 K(-64.7%) | -$4.81 M(-11.3%) |
| Jan 2020 | - | -$1.42 M(+21.1%) | -$5.42 M(+1.1%) |
| Oct 2019 | - | -$1.17 M(-31.4%) | -$5.36 M(+3.8%) |
| July 2019 | -$5.07 M(+32.6%) | -$1.71 M(+53.8%) | -$5.16 M(+5.5%) |
| Apr 2019 | - | -$1.11 M(-18.3%) | -$4.89 M(+0.1%) |
| Jan 2019 | - | -$1.36 M(+38.9%) | -$4.89 M(+13.0%) |
| Oct 2018 | - | -$980.10 K(-32.0%) | -$4.33 M(+12.4%) |
| July 2018 | -$3.82 M(+47.9%) | -$1.44 M(+29.9%) | -$3.85 M(+10.4%) |
| Apr 2018 | - | -$1.11 M(+39.1%) | -$3.49 M(+7.7%) |
| Jan 2018 | - | -$797.80 K(+58.6%) | -$3.24 M(+16.5%) |
| Oct 2017 | - | -$503.00 K(-53.4%) | -$2.78 M(+6.8%) |
| July 2017 | -$2.58 M(+54.9%) | -$1.08 M(+25.5%) | -$2.60 M(+50.5%) |
| Apr 2017 | - | -$859.50 K(+154.2%) | -$1.73 M(+51.4%) |
| Jan 2017 | - | -$338.10 K(+4.0%) | -$1.14 M(-27.7%) |
| Oct 2016 | - | -$325.00 K(+58.1%) | -$1.58 M(+0.8%) |
| July 2016 | -$1.67 M(-38.9%) | -$205.60 K(-24.6%) | -$1.57 M(+5.0%) |
| Apr 2016 | - | -$272.50 K(-64.9%) | -$1.49 M(-7.1%) |
| Jan 2016 | - | -$775.30 K(+148.1%) | -$1.61 M(-44.1%) |
| Oct 2015 | - | -$312.50 K(+138.2%) | -$2.87 M(+9.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| July 2015 | -$2.73 M(+523.7%) | -$131.20 K(-66.0%) | -$2.61 M(-1.7%) |
| Apr 2015 | - | -$386.20 K(-81.1%) | -$2.66 M(+12.1%) |
| Jan 2015 | - | -$2.04 M(+3607.5%) | -$2.37 M(+473.1%) |
| Oct 2014 | - | -$55.00 K(-68.6%) | -$413.40 K(-5.9%) |
| July 2014 | -$437.30 K(+3.1%) | -$175.40 K(+75.6%) | -$439.20 K(+23.3%) |
| Apr 2014 | - | -$99.90 K(+20.2%) | -$356.10 K(-5.1%) |
| Jan 2014 | - | -$83.10 K(+2.8%) | -$375.10 K(-6.4%) |
| Oct 2013 | - | -$80.80 K(-12.5%) | -$400.90 K(-6.0%) |
| July 2013 | -$424.30 K(-23.1%) | -$92.30 K(-22.4%) | -$426.50 K(-8.0%) |
| Apr 2013 | - | -$118.90 K(+9.2%) | -$463.70 K(-1.4%) |
| Jan 2013 | - | -$108.90 K(+2.3%) | -$470.50 K(-6.5%) |
| Oct 2012 | - | -$106.40 K(-17.8%) | -$503.30 K(-7.9%) |
| July 2012 | -$551.80 K(-47.6%) | -$129.50 K(+3.0%) | -$546.70 K(-40.8%) |
| Apr 2012 | - | -$125.70 K(-11.3%) | -$922.80 K(-10.6%) |
| Jan 2012 | - | -$141.70 K(-5.4%) | -$1.03 M(-4.0%) |
| Oct 2011 | - | -$149.80 K(-70.4%) | -$1.08 M(+4.1%) |
| July 2011 | -$1.05 M(+224.5%) | -$505.60 K(+114.9%) | -$1.03 M(+81.6%) |
| Apr 2011 | - | -$235.30 K(+27.2%) | -$569.30 K(+13.7%) |
| Jan 2011 | - | -$185.00 K(+71.6%) | -$500.80 K(+36.2%) |
| Oct 2010 | - | -$107.80 K(+161.7%) | -$367.70 K(+16.0%) |
| July 2010 | -$324.60 K(+38.8%) | -$41.20 K(-75.3%) | -$316.90 K(-23.8%) |
| Apr 2010 | - | -$166.80 K(+221.4%) | -$416.10 K(+61.2%) |
| Jan 2010 | - | -$51.90 K(-8.9%) | -$258.20 K(+7.4%) |
| Oct 2009 | - | -$57.00 K(-59.4%) | -$240.40 K(+2.0%) |
| July 2009 | -$233.90 K(+105.0%) | -$140.40 K(+1477.5%) | -$235.60 K(+55.1%) |
| Apr 2009 | - | -$8900.00(-73.9%) | -$151.90 K(-11.3%) |
| Jan 2009 | - | -$34.10 K(-34.7%) | -$171.30 K(+9.3%) |
| Oct 2008 | - | -$52.20 K(-7.9%) | -$156.70 K(+36.5%) |
| July 2008 | -$114.10 K(-11.6%) | -$56.70 K(+100.4%) | -$114.80 K(+17.7%) |
| Apr 2008 | - | -$28.30 K(+45.1%) | -$97.50 K(+18.6%) |
| Jan 2008 | - | -$19.50 K(+89.3%) | -$82.20 K(-23.6%) |
| Oct 2007 | - | -$10.30 K(-73.9%) | -$107.60 K(-14.5%) |
| July 2007 | -$129.10 K(+1401.2%) | -$39.40 K(+203.1%) | -$125.80 K(+45.6%) |
| Apr 2007 | - | -$13.00 K(-71.0%) | -$86.40 K(+17.7%) |
| Jan 2007 | - | -$44.90 K(+57.5%) | -$73.40 K(+157.5%) |
| Oct 2006 | - | -$28.50 K | -$28.50 K |
| July 2006 | -$8600.00 | - | - |
FAQ
- What is BriaCell Therapeutics annual operaing income?
- What is the all time high annual operating profit for BriaCell Therapeutics?
- What is BriaCell Therapeutics annual operating profit year-on-year change?
- What is BriaCell Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for BriaCell Therapeutics?
- What is BriaCell Therapeutics quarterly operating profit year-on-year change?
- What is BriaCell Therapeutics TTM operating income?
- What is the all time high TTM operating profit for BriaCell Therapeutics?
- What is BriaCell Therapeutics TTM operating profit year-on-year change?
What is BriaCell Therapeutics annual operaing income?
The current annual operating profit of BCTX is -$33.33 M
What is the all time high annual operating profit for BriaCell Therapeutics?
BriaCell Therapeutics all-time high annual operaing income is -$8600.00
What is BriaCell Therapeutics annual operating profit year-on-year change?
Over the past year, BCTX annual operaing income has changed by -$10.06 M (-43.22%)
What is BriaCell Therapeutics quarterly operating income?
The current quarterly operating profit of BCTX is -$5.77 M
What is the all time high quarterly operating profit for BriaCell Therapeutics?
BriaCell Therapeutics all-time high quarterly operating income is -$8900.00
What is BriaCell Therapeutics quarterly operating profit year-on-year change?
Over the past year, BCTX quarterly operating income has changed by +$2.73 M (+32.17%)
What is BriaCell Therapeutics TTM operating income?
The current TTM operating profit of BCTX is -$33.33 M
What is the all time high TTM operating profit for BriaCell Therapeutics?
BriaCell Therapeutics all-time high TTM operating income is -$28.50 K
What is BriaCell Therapeutics TTM operating profit year-on-year change?
Over the past year, BCTX TTM operating income has changed by -$6.96 M (-26.38%)